Clinical trial
A 52-week Multicenter, Randomized, Parallel-group Trial in Overweight People Investigating Lifestyle Changes, Mushroom Supplementation and Bupropion to Reduce Adiposity and Cardiometabolic Risk
NCT07806279 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 52-week Multicenter, Randomized, Parallel-group Trial in Overweight People Investigating Lifestyle Changes, Mushroom Supplementation and Bupropion to Reduce Adiposity and Cardiometabolic Risk
- Lead sponsor
- Uppsala University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 30, 2026
- Completion date
- December 31, 2030
- Enrollment
- 250 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cardiometabolic syndrome, obesity and cardiovascular risk, overweight , obesity